All Type of News
Prohibition of Double Opening, unconstitutional vs constitutional?
Over ‘Paragraph 8 of Article 33 of the Medical Law(Prohibition of Double Opening or One Office Per One Person)’ containing the contents ‘Medical personnel cannot open or operate more than one medical institution in an...
Corporate partition, trend among listed pharmaceutical companies
Ildong Pharmaceutical has decided to divide its company including its holding company ‘Ildong Holdings’ into 4 business units.
The Ildong Pharmaceutical’s partition is evaluated as a different meaning from other top ...
Shire Korea, “We will become the best in rare disease and specialty fields”
Specializing in rare disease and specialty fields, Shire Korea has officially been launched.
A multinational pharmaceutical company, Shire announced the Shire Korea’s(CEO Hui-seok Moon) official launch and its futur...
Green Cross’s exports flying the largest ever with order of influenza vaccinesOn the 9th, Green Cross(CEO Eun-cheol Huh) announced winning an order of approximately USD 32 million(KRW 38.7 billion) influenza vaccines at the 2016’s southern hemisphere supp...
|
Foreign expansion of hypertension/hyperlipidemia complexes
Domestic hypertension and hyperlipidemia complexes have aggressively knocked on the door of foreign markets. They have either been directly conducted on foreign clinical trials or been jointly developed with global bi...
Spread of joint venture(JV) establishment among pharmaceutical companies
Localization of pharmaceutical companies in the top sales positions has been accelerated. Their future strategies to focus on global expansion is getting visualized.
According to the industry concerned on the 9th, th...
Newest trend in ‘pharmaceutical/medical advertisement’ market
The 2015’s pharmaceutical and medical advertisement market was ranked on the 6th in the entire industry group based on the amount of investments. The cosmetic and health product advertisement market was positioned at ...
LAMA+LABA complex, ‘Vahelva Respimat’ launches with insurance benefit on April
A new LAMA+LABA complex drug, Vahelva Respimat(generic name: tiotropium+olodaterol) is expected to be launched on April 1.
On the 8th, Boehringer Ingelheim(CEO Gi-hwan Park) introduced Vahelva Respimat and Spiriva R...
Pharmaceutical co-marketing between multinational companies and distribution companies
Pharmaceutical co-marketing, which has usually been performed between multinational pharmaceutical companies and domestic ones, has also been made actively between multinational ones and pharmaceutical distribution co...
CRM market attracting foreign market with pharmaceutical R&D investment increase
As pharmaceutical companies’ R&D investments for new drug develop rise and the biopharmaceutical industry has become the future growth engine, it was suggested the CRO(Contract Research Organization) market will also ...
